Coty (COTY)
The desk's stance
On our research list, not on the slate.
What the company does
CoverGirl, Rimmel, and a stable of licensed fragrances — the legacy mass house whose stock has collapsed to penny-adjacent levels while e.l.f. eats its shelf.
In short: Global fragrance and cosmetics manufacturer. Category: Legacy Mass Prestige Beauty. Sector: Consumer Defensive, Household & Personal Products.
G-Street Value and Score
G-Street Value: $2.45, computed Oct 18, 2026 (confidence: medium).
How we got there: 50% analyst leg $2.45 (street consensus, after 8% optimism discount) + 50% GainStreet factor value $3.7 (15.24× fwd EPS anchored to consumer-defensive multiples) — capped at the analyst leg; factors never out-bull the street. 4 analyst targets have no linked source and are shown but not counted; this value will not open a position until they are sourced.
G-Street Score: 42 out of 100 (Weak).
- Top-line growth & guidance: 7 of 32
- Margin power: 8 of 15
- Revenue visibility & quality: 6 of 11
- Profitability & balance sheet: 12 of 24
- Capital allocation & governance: 5 of 6
- Valuation, sentiment & momentum: 4 of 12
Our current thesis
Updated Oct 17, 2026
The thesis
- Prestige fragrance licensing and resilient $348M annual FCF support continuous debt paydown.
- Cash proceeds from Wella monetization and the Gucci license transition accelerate balance sheet deleveraging.
Risks
- Consumer Beauty continuously loses mass shelf space to agile competitors like e.l.f.
- Four consecutive quarterly EPS misses and negative 10.4% profit margins demonstrate operational drag.
- Early Gucci license transition creates significant medium-term organic revenue and royalty replacement headwinds.
What we're watching
- Fiscal Q1 2027 earnings on November 4, 2026 for organic sales trajectory.
- Progress toward reducing total debt below $3.0B via asset proceeds and FCF.
- Outcome of the Consumer Beauty strategic portfolio review by late calendar 2026.
Latest
Coty trades at $3.20 after a 30% one-month rally, outpacing consensus price targets despite four consecutive EPS misses and a -$618M trailing net loss. Net debt remains elevated at $3.12B against $176M in cash, although FY2026 free cash flow improved to $348M. Forward revenue faces low-to-mid single-digit declines ahead of the Gucci license exit and ongoing mass retail share erosion.
Key numbers
As of Oct 16, 2026: market cap $2.8B · revenue growth +1.3% year over year · gross margin 62.9% · net margin -10.4% · forward P/E 13.2 · next earnings Nov 4, 2026.
On the Gainz Lab maps
Who it does business with
- e.l.f. Beauty competes with Coty — Drugstore shelf. Every inch e.l.f. gains at Target and Walmart tends to come out of CoverGirl's planogram.
- Coty competes with Revlon — Legacy mass decline. The old drugstore names fighting over a shrinking legacy shelf while the value disruptors take the growth.